Reverse Transcription

Reverse Transcription is the enzymatic process converting RNA molecules into complementary DNA (cDNA), catalysed by reverse transcriptase enzymes that synthesise DNA strands using RNA templates. This fundamental molecular biology technique enables analysis of gene expression patterns, viral detection, and various genomic applications critical to biopharmaceutical research and diagnostics.

Discovered in retroviruses where it facilitates viral genome integration into host chromosomes, reverse transcription contradicted the central dogma's original formulation. The process begins when reverse transcriptase binds RNA templates, generating cDNA copies that can subsequently undergo amplification through PCR, creating the widely-used RT-PCR technique. The biopharmaceutical sector depends heavily on reverse transcription technology across multiple applications. Researchers employ RT-PCR to measure mRNA levels comparing gene expression between healthy and diseased tissues or evaluating how drug candidates alter cellular responses. Quality control laboratories utilise RT-PCR to detect adventitious RNA viruses potentially contaminating biologic products. The COVID-19 pandemic highlighted reverse transcription's diagnostic importance, with RT-PCR tests becoming the gold standard for detecting SARS-CoV-2 viral RNA. Drug developers studying RNA-based therapeutics leverage reverse transcription to track their molecular targets. Next-generation sequencing workflows incorporate reverse transcription steps, enabling transcriptome profiling identifying disease biomarkers and therapeutic targets.